These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 34027208)
1. Association of serum sialic acid concentration with diabetic complications and cardiovascular risk factors in an Indian population. Bansal P; Bansal P; Verma R Arch Med Sci Atheroscler Dis; 2021; 6():e14-e17. PubMed ID: 34027208 [TBL] [Abstract][Full Text] [Related]
2. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients. Nayak SB; Bhaktha G Lipids Health Dis; 2005 Aug; 4():15. PubMed ID: 16092968 [TBL] [Abstract][Full Text] [Related]
3. Effect of Non-Surgical Periodontal Therapy on the Serum Sialic Acid Levels in Diabetic Patients with Periodontitis. Suresh R; Jayachandran P; Fenol A; Biswas R; Krishnan S; Kumar KA; Divakar DD; Vellappally S Acta Medica (Hradec Kralove); 2019; 62(3):109-116. PubMed ID: 31663504 [TBL] [Abstract][Full Text] [Related]
4. Relationship between inflammatory markers, metabolic and anthropometric variables in the Caribbean type 2 diabetic patients with and without microvascular complications. Nayak BS; Roberts L J Inflamm (Lond); 2006 Dec; 3():17. PubMed ID: 17187674 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of serum sialic Acid in type-2 diabetes mellitus and its complication (nephropathy). K P; Kumar J A; Rai S; Shetty SK; Rai T; Shrinidhi ; Begum M; Md S J Clin Diagn Res; 2013 Nov; 7(11):2435-7. PubMed ID: 24392365 [TBL] [Abstract][Full Text] [Related]
6. Serum Total Sialic Acid and Highly Sensitive C-reactive Protein: Prognostic Markers for the Diabetic Nephropathy. Varma V; Varma M; Varma A; Kumar R; Bharosay A; Vyas S J Lab Physicians; 2016; 8(1):25-9. PubMed ID: 27013809 [TBL] [Abstract][Full Text] [Related]
7. [Serum levels of sialic acid in patients with type 1 diabetes mellitus in relation to the incidence of late complications]. Spunda J; Neumann M; Bartásková D; Kvapil M Cas Lek Cesk; 1996 Nov; 135(22):723-5. PubMed ID: 8998824 [TBL] [Abstract][Full Text] [Related]
8. The correlation between blood oxidative stress and sialic acid content in diabetic patients with nephropathy, hypertension, and hyperlipidemia. Shahvali S; Shahesmaeili A; Sanjari M; Karami-Mohajeri S Diabetol Int; 2020 Jan; 11(1):19-26. PubMed ID: 31950000 [TBL] [Abstract][Full Text] [Related]
9. Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study. Babaliche P; Nadpara RA; Maldar A J Natl Med Assoc; 2019 Feb; 111(1):83-87. PubMed ID: 30032867 [TBL] [Abstract][Full Text] [Related]
10. Significance of serum and urine neuraminidase activity and serum and urine level of sialic acid in diabetic nephropathy. Roozbeh J; Merat A; Bodagkhan F; Afshariani R; Yarmohammadi H Int Urol Nephrol; 2011 Dec; 43(4):1143-8. PubMed ID: 21207147 [TBL] [Abstract][Full Text] [Related]
11. Serum level of sialic acid (SA) and carbohydrate-deficient transferrin (CDT) in type 2 diabetes mellitus with microvascular complications. Cylwik B; Chrostek L; Jakimiuk B; Popławska A; Szmitkowski M J Clin Lab Anal; 2006; 20(2):68-73. PubMed ID: 16538641 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Crook MA; Tutt P; Pickup JC Diabetes Care; 1993 Jan; 16(1):57-60. PubMed ID: 8422833 [TBL] [Abstract][Full Text] [Related]
13. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM. García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060 [TBL] [Abstract][Full Text] [Related]
14. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Crook MA; Tutt P; Simpson H; Pickup JC Clin Chim Acta; 1993 Oct; 219(1-2):131-8. PubMed ID: 7508342 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of sialic acids in healthy humans and different disorders. Sillanaukee P; Pönniö M; Jääskeläinen IP Eur J Clin Invest; 1999 May; 29(5):413-25. PubMed ID: 10354198 [TBL] [Abstract][Full Text] [Related]
16. Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus. Azenabor A; Ogbera AO; Adejumo NE; Adejare AO J Res Med Sci; 2011 Oct; 16(10):1298-305. PubMed ID: 22973323 [TBL] [Abstract][Full Text] [Related]
17. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432 [TBL] [Abstract][Full Text] [Related]
18. Conflicting interactions of apolipoprotein A and high density lipoprotein cholesterol with microvascular complications of type 2 diabetes. Aryan Z; Afarideh M; Ghajar A; Esteghamati S; Esteghamati A; Nakhjavani M Diabetes Res Clin Pract; 2017 Nov; 133():131-141. PubMed ID: 28934670 [TBL] [Abstract][Full Text] [Related]
19. Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus. Powrie JK; Watts GF; Crook MA; Ingham JN; Taub NA; Shaw KM Diabet Med; 1996 Mar; 13(3):238-42. PubMed ID: 8689844 [TBL] [Abstract][Full Text] [Related]
20. Serum Total Sialic Acid Level is Elevated in Hypothyroid Patients as an Atherosclerotic Risk Factor. Altay M; Karakoç MA; Çakır N; Yılmaz Demirtaş C; Cerit ET; Aktürk M; Ateş İ; Bukan N; Arslan M J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27457058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]